Momentus Inc. Announces First Quarter 2023 Financial Results
“Momentus is showing its competitive advantages with flight heritage, early success with our pioneering water-based propellant engine, and a vehicle that can respond to customer needs with flexibility, speed, and a lower cost,” said Momentus Chief Executive Officer John Rood. “We are now operating Vigoride-5 and Vigoride-6 concurrently, and both missions mark key milestones in demonstrating the value proposition of our technology. In less than a year we have launched three of our Vigoride Orbital Service Vehicles into space, deployed nine customer payloads, provided hosted payload services, demonstrated a new, differentiated breed of spacecraft engine, and continue to garner interest with commercial and government customers.”
“The Vigoride Orbital Service Vehicle has a large and flexible payload capacity, best-in-class power, and is low cost,” continued Rood. “We’re eager to use the unique attributes of Vigoride to meet government use cases as well as commercial needs. We have made progress demonstrating our value for
Recent Business Highlights:
-
Launched Vigoride-5 aboard the SpaceX Transporter-6 mission from
Cape Canaveral, Florida . This vehicle incorporated important lessons learned from Momentus’ inaugural mission that launched in 2022. On this ongoing mission, Momentus is providing hosted payload services for Caltech’s Space-based Solar Power Project payload, and recently deployed a payload for an international customer.
-
Demonstrated success with Momentus’ Microwave Electrothermal Thruster (“MET”) that uses distilled water as propellant. Testing has continued subsequent to the quarter and to date the MET has achieved more than 35 firings ranging from 30 seconds up to six minutes in duration. The duration of the six minute firing exceeded by
20% the maximum planned duration for operation of the MET on this mission. Cumulatively, Momentus has reached over 140 minutes of firing time of the MET system. Momentus has now operated the MET successfully in space at full power across the range of durations for firing that we plan to use operationally to deliver satellites to precise, custom orbits and to provide in-space infrastructure services like hosted payloads.
- The MET achieved a key task of its Vigoride-5 mission by raising the orbit of the spacecraft by more than 3 km. Orbital altitude raises are an integral part of Momentus’ orbital transportation service offering that aims to deliver customer satellites to precise and custom orbits.
- Signed a services agreement with repeat customer, FOSSA Systems, to place its latest generation of satellites into Low-Earth Orbit. This agreement represents initial progress toward Momentus’ first large-scale constellation deployment.
- Signed a services agreement with FOSSA Systems to fly a picosatellite deployer with the capacity for eight pocketqube satellites as part of its launch brokerage capabilities and services. This deployer will house several satellites serving different IoT, Earth Observation, and demonstration platforms for yet-to-be-announced customers.
- Signed a services agreement with Hello Space to provide hosted payload service for a deployer carrying four pocketqubes. These pocketqube satellites mark the first tranche of an 80-satellite constellation set by Hello Space.
- Signed a services agreement with Lunasonde to deliver a cubesat to orbit from the Vigoride-7 mission targeted for launch in October on the SpaceX Transporter-9 mission.
- Signed a services agreement with SatRev for the delivery of a cubesat to Low-Earth Orbit also on the Vigoride-7 mission.
- Signed a services agreement with a yet-to-be-named customer for the orbital delivery of the first tranche of picosats for a 100-satellite planned constellation.
- Were selected for funding from the Space Development Agency for a Small Business Innovation Research Phase 2 award, which SDA is collaborating to complete with the Air Force Research Lab Technology Directorate AFWERX.
- Signed a Memorandum of Understanding with Axient, a well-established company with a strong track record in defense and classified work for the Defense Department.
- Launched the Vigoride-6 OSV on the SpaceX Transporter-7 mission. The vehicle is carrying the NASA LLITED mission, payloads for multiple commercial customers, and a Momentus-developed solar array technology demo with a focus of reducing Vigoride unit manufacturing costs and lead times.
- Signed a launch services agreement with SpaceX securing launch opportunities through the end of 2024.
- Teamed with another commercial company to respond to NASA’s Hubble Reboost RFI in a joint proposal. The mission’s objectives include safe relocation of Hubble and removal of nearby threatening debris from the celebrated space telescope’s new orbit.
Conference Call Information
Momentus will host a conference call to discuss the results today at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). To access the conference call, participants should dial +1 (800) 715-9871 and enter the conference ID number 9685779. International participants should dial +1 (646) 307-1963. The live audio webcast along with supplemental information will be accessible on the Company’s Investor Relations website at https://investors.momentus.space. A recording of the webcast will also be available following the conference call.
About Momentus Inc.
Momentus is a
Forward-Looking Statements
This press release contains certain statements which may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding Momentus or its management team’s expectations, hopes, beliefs, intentions or strategies regarding the future, projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, and are not guarantees of future performance. The words “may,” “will,” “anticipate,” “believe,” “expect,” “continue,” “could,” “estimate,” “future,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “aim,” “strive,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions.
Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Momentus’ control. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: the ability of the Company to raise additional capital to finance its longer-term business plan; the ability of the Company to obtain licenses and government approvals for its missions, which are essential to its operations; the ability of the Company to effectively market and sell satellite transport services and planned in-orbit services; the ability of the Company to protect its intellectual property and trade secrets; the development of markets for satellite transport and in-orbit services; the ability of the Company to develop, test and validate its technology, including its water plasma propulsion technology; delays or impediments that the Company may face in the development, manufacture and deployment of next generation satellite transport systems; the ability of the Company to convert backlog or inbound inquiries into revenue; changes in applicable laws or regulations and extensive and evolving government regulations that impact operations and business, including export control license requirements; the ability to attract or maintain a qualified workforce with the required security clearances and requisite skills; product service or product or launch failures or delays that could lead customers to use competitors’ services; investigations, claims, disputes, enforcement actions, litigation and/or other regulatory or legal proceedings; the Company’s ability to comply with the terms of its National Security Agreement and any related compliance measures instituted by the director who was approved by the CFIUS Monitoring Agencies (the “Security Director”); the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; and/or other risks and uncertainties. These are only some of the factors that may affect the forward-looking statements contained in this press release. For a discussion identifying additional important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, see the company’s filings with the
First Quarter 2023 Financial Results
MOMENTUS INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (in thousands, except share data) |
|||||||
|
Three Months Ended March 31, |
||||||
|
|
2023 |
|
|
|
2022 |
|
Service revenue |
$ |
22 |
|
|
$ |
— |
|
Gross profit |
|
22 |
|
|
|
— |
|
Operating expenses: |
|
|
|
||||
Research and development expenses |
|
10,119 |
|
|
|
9,971 |
|
Selling, general and administrative expenses |
|
10,270 |
|
|
|
14,853 |
|
Total operating expenses |
|
20,389 |
|
|
|
24,824 |
|
Loss from operations |
|
(20,367 |
) |
|
|
(24,824 |
) |
|
|
|
|
||||
Other income (expense): |
|
|
|
||||
Change in fair value of warrant liability |
|
(112 |
) |
|
|
(451 |
) |
Realized loss on disposal of asset |
|
— |
|
|
|
(70 |
) |
Interest income |
|
555 |
|
|
|
— |
|
Interest expense |
|
(920 |
) |
|
|
(1,492 |
) |
Litigation settlement, net |
|
— |
|
|
|
3 |
|
Other income |
|
19 |
|
|
|
— |
|
Total other expense |
|
(458 |
) |
|
|
(2,010 |
) |
Net loss |
$ |
(20,825 |
) |
|
$ |
(26,834 |
) |
Net loss per share, basic |
$ |
(0.24 |
) |
|
$ |
(0.34 |
) |
Net loss per share, fully diluted |
$ |
(0.24 |
) |
|
$ |
(0.34 |
) |
Weighted average shares outstanding, basic |
|
87,559,611 |
|
|
|
79,958,383 |
|
Weighted average shares outstanding, fully diluted |
|
87,559,611 |
|
|
|
79,958,383 |
|
MOMENTUS INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) |
|||||||
|
March 31,
|
|
December 31,
|
||||
|
(unaudited) |
|
|
||||
ASSETS |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
38,630 |
|
|
$ |
61,094 |
|
Restricted cash, current |
|
879 |
|
|
|
1,007 |
|
Insurance receivable |
|
4,000 |
|
|
|
4,000 |
|
Prepaids and other current assets |
|
9,524 |
|
|
|
10,173 |
|
Total current assets |
|
53,033 |
|
|
|
76,274 |
|
Property, machinery and equipment, net |
|
3,844 |
|
|
|
4,016 |
|
Intangible assets, net |
|
340 |
|
|
|
337 |
|
Operating right-of-use asset |
|
6,174 |
|
|
|
6,441 |
|
Deferred offering costs |
|
418 |
|
|
|
331 |
|
Restricted cash, non-current |
|
363 |
|
|
|
312 |
|
Other non-current assets |
|
4,670 |
|
|
|
4,712 |
|
Total assets |
$ |
68,842 |
|
|
$ |
92,423 |
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
||||
Accounts payable |
$ |
2,092 |
|
|
$ |
2,239 |
|
Accrued expenses |
|
6,496 |
|
|
|
8,026 |
|
Loan payable, current |
|
11,290 |
|
|
|
11,627 |
|
Contract liabilities, current |
|
2,136 |
|
|
|
1,654 |
|
Operating lease liability, current |
|
1,181 |
|
|
|
1,153 |
|
Stock repurchase liability |
|
— |
|
|
|
10,000 |
|
Litigation settlement contingency |
|
8,500 |
|
|
|
8,500 |
|
Other current liabilities |
|
36 |
|
|
|
27 |
|
Total current liabilities |
|
31,731 |
|
|
|
43,226 |
|
Contract liabilities, non-current |
|
1,026 |
|
|
|
1,026 |
|
Loan Payable, non-current |
|
171 |
|
|
|
2,404 |
|
Warrant liability |
|
676 |
|
|
|
564 |
|
Operating lease liability, non-current |
|
5,821 |
|
|
|
6,131 |
|
Other non-current liabilities |
|
471 |
|
|
|
465 |
|
Total non-current liabilities |
|
8,165 |
|
|
|
10,590 |
|
Total liabilities |
|
39,896 |
|
|
|
53,816 |
|
Commitment and Contingencies (Note 12) |
|
|
|
||||
Stockholders’ equity: |
|
|
|
||||
Common stock, |
|
1 |
|
|
|
1 |
|
Additional paid-in capital |
|
353,897 |
|
|
|
342,733 |
|
Accumulated deficit |
|
(324,952 |
) |
|
|
(304,127 |
) |
Total stockholders’ equity |
|
28,946 |
|
|
|
38,607 |
|
Total liabilities and stockholders’ equity |
$ |
68,842 |
|
|
$ |
92,423 |
|
MOMENTUS INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (in thousands) |
|||||||
|
Three Months Ended March |
||||||
|
|
2023 |
|
|
|
2022 |
|
Cash flows from operating activities: |
|
|
|
||||
Net loss |
$ |
(20,825 |
) |
|
$ |
(26,834 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
||||
Depreciation and amortization |
|
229 |
|
|
|
294 |
|
Amortization of debt discount and issuance costs |
|
492 |
|
|
|
742 |
|
Amortization of right-of-use asset |
|
267 |
|
|
|
322 |
|
Change in fair value of warrant liability |
|
112 |
|
|
|
451 |
|
Loss on disposal of property, machinery, equipment and intangible assets |
|
— |
|
|
|
70 |
|
Stock-based compensation expense |
|
1,720 |
|
|
|
2,212 |
|
Issuance of common stock to non-employees |
|
57 |
|
|
|
— |
|
Changes in operating assets and liabilities: |
|
|
|
||||
Prepaids and other current assets |
|
704 |
|
|
|
1,447 |
|
Other non-current assets |
|
41 |
|
|
|
(2,685 |
) |
Accounts payable |
|
(211 |
) |
|
|
1,387 |
|
Accrued expenses |
|
(1,538 |
) |
|
|
(273 |
) |
Accrued interest |
|
39 |
|
|
|
13 |
|
Other current liabilities |
|
12 |
|
|
|
14 |
|
Contract liabilities |
|
481 |
|
|
|
100 |
|
Lease liability |
|
(282 |
) |
|
|
(328 |
) |
Other non-current liabilities |
|
6 |
|
|
|
6 |
|
Net cash used in operating activities |
|
(18,696 |
) |
|
|
(23,062 |
) |
|
|
|
|
||||
Cash flows from investing activities: |
|
|
|
||||
Purchases of property, machinery and equipment |
|
(43 |
) |
|
|
(290 |
) |
Purchases of intangible assets |
|
(9 |
) |
|
|
(231 |
) |
Net cash used in investing activities |
|
(52 |
) |
|
|
(521 |
) |
|
|
|
|
||||
Cash flows from financing activities: |
|
|
|
||||
Proceeds from exercise of stock options |
|
92 |
|
|
|
48 |
|
Repurchase of Section 16 Officer shares for tax coverage exchange |
|
(60 |
) |
|
|
(59 |
) |
Principal payments on loan payable |
|
(3,102 |
) |
|
|
(927 |
) |
Payment of deferred offering costs |
|
(23 |
) |
|
|
— |
|
Payment for repurchase of common shares |
|
(10,000 |
) |
|
|
— |
|
Proceeds from issuance of common stock and related warrants |
|
10,000 |
|
|
|
— |
|
Payments for issuance costs related to common stock and related warrants |
|
(700 |
) |
|
|
— |
|
Net cash used in financing activities |
|
(3,793 |
) |
|
|
(938 |
) |
|
|
|
|
||||
Decrease in cash, cash equivalents and restricted cash |
|
(22,541 |
) |
|
|
(24,521 |
) |
Cash, cash equivalents and restricted cash, beginning of period |
|
62,413 |
|
|
|
160,547 |
|
Cash, cash equivalents and restricted cash, end of period |
$ |
39,872 |
|
|
$ |
136,026 |
|
|
|
|
|
||||
Supplemental disclosure of non-cash investing and financing activities |
|
|
|
||||
Purchases of intangibles assets in accounts payable and accrued expenses at period end |
$ |
7 |
|
|
$ |
— |
|
Deferred offering costs in accounts payable and accrued expenses at period end |
$ |
64 |
|
|
$ |
— |
|
Stock repurchase liability fair value |
$ |
— |
|
|
$ |
6,000 |
|
|
|
|
|
||||
Supplemental disclosure of cash flow information |
|
|
|
||||
Cash paid for income taxes |
$ |
— |
|
|
$ |
— |
|
Cash paid for interest |
$ |
389 |
|
|
$ |
750 |
|
Reclassifications
Certain reclassifications have been made to the prior year’s financial statements to conform to the current year’s presentation. None of the reclassifications have changed the total assets, liabilities, shareholders’ deficit, income, expenses or net losses previously reported.
Use of Non-GAAP Financial Measures (unaudited)
This press release references certain non-GAAP financial measures, including adjusted EBITDA, non-GAAP selling, general, and administrative expense and non-GAAP research and development expense. The Company defines adjusted EBITDA as earnings before interest expense, taxes, depreciation and amortization, stock-based compensation, and certain other items the Company believes are not indicative of its core operating performance. The Company defines non-GAAP selling, general, and administrative expenses and research and development expenses as those respective GAAP amounts, excluding stock-based compensation and non-recurring items not indicative of core operating performance None of these non-GAAP financial measures is a substitute for or superior to measures of financial performance prepared in accordance with generally accepted accounting principles in
The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company that is helpful in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently, or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.
Quarterly adjusted EBITDA
A reconciliation of adjusted EBITDA to net loss for the three months ended March 31, 2023, March 31, 2022, and December 31, 2022, is set forth below:
|
Three Months Ended |
||||||||||
(in thousands) |
March 31, 2023 |
|
March 31, 2022 |
|
December 31, 2022 |
||||||
Net loss |
$ |
(20,825 |
) |
|
$ |
(26,834 |
) |
|
$ |
(24,440 |
) |
Income tax expense |
|
— |
|
|
|
— |
|
|
|
— |
|
Interest income |
|
(555 |
) |
|
|
— |
|
|
|
(489 |
) |
Interest expense |
|
920 |
|
|
|
1,492 |
|
|
|
1,096 |
|
Depreciation & amortization |
|
229 |
|
|
|
294 |
|
|
|
259 |
|
EBITDA |
|
(20,231 |
) |
|
|
(25,048 |
) |
|
|
(23,574 |
) |
Increase (decrease) in fair value of warrants |
|
112 |
|
|
|
451 |
|
|
|
(1,803 |
) |
Realized loss on disposal of assets |
|
— |
|
|
|
70 |
|
|
|
54 |
|
Litigation settlement, net |
|
— |
|
|
|
(3 |
) |
|
|
4,500 |
|
Prepaid launch deposit impairment |
|
514 |
|
|
|
— |
|
|
|
— |
|
SEC and CFIUS legal expenses |
|
85 |
|
|
|
795 |
|
|
|
161 |
|
Class action litigation legal expenses |
|
110 |
|
|
|
795 |
|
|
|
755 |
|
Other non-recurring litigation legal expense |
|
1,219 |
|
|
|
114 |
|
|
|
1,004 |
|
SEC compliance costs |
|
22 |
|
|
|
2,135 |
|
|
|
76 |
|
NSA compliance costs |
|
232 |
|
|
|
978 |
|
|
|
233 |
|
Severance and other non-recurring expenses1 |
|
122 |
|
|
|
350 |
|
|
|
— |
|
Stock-based compensation |
|
1,720 |
|
|
|
2,212 |
|
|
|
3,044 |
|
Adjusted EBITDA |
$ |
(16,095 |
) |
|
$ |
(17,151 |
) |
|
$ |
(15,550 |
) |
1 - Loss contingencies for certain severance agreements were reversed when the Company determined they would not be signed and paid
A reconciliation of selling, general, and administrative expenses to non-GAAP selling, general, and administrative expenses for the three months ended March 31, 2023, March 31, 2022, and December 31, 2022, is set forth below:
|
Three Months Ended |
|||||||
(in thousands) |
March 31, 2023 |
|
March 31, 2022 |
|
December 31, 2022 |
|||
Selling, general, and administrative expenses |
$ |
10,270 |
|
$ |
14,853 |
|
$ |
10,929 |
Stock-based compensation |
|
1,244 |
|
|
1,839 |
|
|
2,534 |
SEC and CFIUS legal expenses |
|
85 |
|
|
795 |
|
|
161 |
Class action litigation legal expenses |
|
110 |
|
|
795 |
|
|
755 |
Other non-recurring litigation legal expense |
|
1,219 |
|
|
114 |
|
|
1,004 |
SEC compliance costs |
|
22 |
|
|
2,135 |
|
|
76 |
NSA compliance costs |
|
232 |
|
|
978 |
|
|
233 |
Severance and other non-recurring expenses1 |
|
— |
|
|
— |
|
|
— |
Non-GAAP selling, general, administration expenses |
$ |
7,358 |
|
$ |
8,197 |
|
$ |
6,166 |
1 - Loss contingencies for certain severance agreements were reversed when the Company determined they would not be signed and paid
A reconciliation of research and development expenses to non-GAAP research and development expenses for the three months ended March 31, 2023, March 31, 2022, and December 31, 2022, is set forth below:
|
Three Months Ended |
|||||||
(in thousands) |
March 31, 2023 |
|
March 31, 2022 |
|
December 31, 2022 |
|||
Research and development expenses |
$ |
10,119 |
|
$ |
9,971 |
|
$ |
10,283 |
Prepaid launch deposit impairment |
|
514 |
|
|
— |
|
|
— |
Stock-based compensation |
|
476 |
|
|
373 |
|
|
510 |
Severance and non-recurring expenses1 |
|
122 |
|
|
350 |
|
|
— |
Non-GAAP Research and development expenses |
$ |
9,007 |
|
$ |
9,248 |
|
$ |
9,773 |
1 - Loss contingencies for certain severance agreements were reversed when the Company determined they would not be signed and paid
View source version on businesswire.com: https://www.businesswire.com/news/home/20230511005781/en/
For media inquiries:
press@momentus.space
For investor relations inquiries:
investors@momentus.space
Source: Momentus Inc.